Literature DB >> 12904840

Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial.

Geeta Hampson1, Finbarr C Martin, Kate Moffat, Sashie Vaja, Suki Sankaralingam, Joseph Cheung, Glen M Blake, Ignac Fogelman.   

Abstract

Malnutrition in elderly people contributes to osteoporosis and fracture. The aim of the study was to investigate the effects of nutritional improvement on bone metabolism in elderly community-dwelling women. A 12-month randomized controlled trial of 71 ambulant women aged > or =70 years with BMI < or =21 kg/m(2 )and osteoporosis at the hip was undertaken. They received either calcium (1 g) and vitamin D (800 units of cholecalciferol) only (group 1: n=35) or calcium/vitamin D and one or two cartons of a nutritional supplement drink which provided 300 Kcal, 12 g protein, 11.6 g fat and 36.8 g carbohydrate per carton (group 2: n=36). Body composition and bone mineral density (BMD) were assessed at baseline and 12 months. Biochemical markers of bone turnover were measured at baseline and at 1, 3, 6, 9 and 12 months. Group 2 gained significantly more weight [mean (SD) group 1: 0.15 (2.45), group 2:2.66 (2.8) kg P<0.001] and fat mass [group 1: -0.26 (1.8), group 2:1.9 (1.7) kg P<0.001]. BMD at the spine, femoral neck and total hip did not change significantly, although there was a positive trend at the total hip in group 2 [group 1: -0.5 (5.2), group 2:1.25 (3.3)%, P=0.13]. In a subgroup analysis, irrespective of their treatment group, there was a significant difference in changes in BMD at the lumbar spine and total hip in those who lost body weight (A) compared to those who had maintained or increased their weight (B), [mean (SD) % change in BMD lumbar spine; A: -1.64 (3.75), B: 0.96 (2.75) P=0.013, total hip A: -2.09 (6.0), B: 1.04 (3.3), P=0.05)] A significant reduction in serum CTX, a marker of bone resorption, was seen in group 2 [% decrease at 3 months, group 1: 1 (8.7), Group 2: 32 (5.8), P<0.01]. Serum osteoprotegerin (OPG) increased significantly in group 2 with a maximal increase (27%) observed at 6 ( P<0.01) and 9 months ( P<0.05). A small increase in bone-specific alkaline phosphatase was seen at 12 months in group 2 [% increase group 1:5 (5), group 2: 17 (6), P=0.05]. Serum osteocalcin increased at 12 months in group 2 ( P=0.01). Dietary improvement in elderly women with low BMI is associated with a reduction in bone resorption with a small but "net" positive effect on bone formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904840     DOI: 10.1007/s00198-003-1440-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  26 in total

1.  Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

Authors:  C H Chesnut; N H Bell; G S Clark; B L Drinkwater; S C English; C C Johnson; M Notelovitz; C Rosen; D F Cain; K A Flessland; N J Mallinak
Journal:  Am J Med       Date:  1997-01       Impact factor: 4.965

Review 2.  The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

Authors:  L C Hofbauer; S Khosla; C R Dunstan; D L Lacey; W J Boyle; B L Riggs
Journal:  J Bone Miner Res       Date:  2000-01       Impact factor: 6.741

3.  Evaluation of a mental test score for assessment of mental impairment in the elderly.

Authors:  H M Hodkinson
Journal:  Age Ageing       Date:  1972-11       Impact factor: 10.668

4.  Serum osteocalcin regulation in protein-energy malnourished children.

Authors:  B Ndiaye; D Lemonnier; M G Sall; C Prudhon; B Diaham; F Zeghoud; H Guillozo; N Leite; S Wade
Journal:  Pediatr Res       Date:  1995-05       Impact factor: 3.756

5.  Determinants of the rate of bone loss in normal postmenopausal women.

Authors:  I R Reid; R W Ames; M C Evans; S J Sharpe; G D Gamble
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

6.  Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study.

Authors:  P Garnero; P Dargent-Molina; D Hans; A M Schott; G Bréart; P J Meunier; P D Delmas
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

7.  Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.

Authors:  Somnath Sarkar; Bruce H Mitlak; Mayme Wong; John L Stock; Dennis M Black; Kristine D Harper
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

8.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

Review 9.  Physical activity and muscle training in the elderly.

Authors:  G Grimby
Journal:  Acta Med Scand Suppl       Date:  1986

10.  Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women.

Authors:  K Akesson; S Ljunghall; B Jonsson; I Sernbo; O Johnell; P Gärdsell; K J Obrant
Journal:  J Bone Miner Res       Date:  1995-11       Impact factor: 6.741

View more
  10 in total

1.  Canadian Consensus Conference on osteoporosis, 2006 update.

Authors:  Jacques P Brown; Michel Fortier; Heather Frame; André Lalonde; Alexandra Papaioannou; Vyta Senikas; Chui Kin Yuen
Journal:  J Obstet Gynaecol Can       Date:  2006-02

2.  The effect of fruit and vegetable powder mix on hypertensive subjects: a pilot study.

Authors:  John Zhang; George Oxinos; John H Maher
Journal:  J Chiropr Med       Date:  2009-09

Review 3.  The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials.

Authors:  S Soltani; G R Hunter; A Kazemi; S Shab-Bidar
Journal:  Osteoporos Int       Date:  2016-05-06       Impact factor: 4.507

Review 4.  Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults.

Authors:  Christine Baldwin; Marian Ae de van der Schueren; Hinke M Kruizenga; Christine Elizabeth Weekes
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

5.  Zinc increases the effects of essential amino acids-whey protein supplements in frail elderly.

Authors:  A Rodondi; P Ammann; S Ghilardi-Beuret; R Rizzoli
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

Review 6.  Protein and energy supplementation in elderly people at risk from malnutrition.

Authors:  Anne C Milne; Jan Potter; Angela Vivanti; Alison Avenell
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

7.  Taking nutritional supplements for three months reduced blood pressure but not blood lipid levels in students.

Authors:  John Zhang; Rebecca Bateman; Shastidy Metzger; Kurt Lanigan
Journal:  J Chiropr Med       Date:  2006

8.  Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults.

Authors:  Christine Baldwin; Christine Elizabeth Weekes
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

Review 9.  Protein/amino-acid modulation of bone cell function.

Authors:  Robert MacDonell; Mark W Hamrick; Carlos M Isales
Journal:  Bonekey Rep       Date:  2016-08-10

10.  Impact of dietary aromatic amino acids on osteoclastic activity.

Authors:  Mona El Refaey; Qing Zhong; Ke-Hong Ding; Xing-Ming Shi; Jianrui Xu; Wendy B Bollag; William D Hill; Norman Chutkan; Richard Robbins; Hugh Nadeau; Maribeth Johnson; Mark W Hamrick; Carlos M Isales
Journal:  Calcif Tissue Int       Date:  2014-07-08       Impact factor: 4.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.